The Russell 2014 Annual Reconstitution changes will be announced on Friday, June 13 AFTER CLOSE. So have to wait for Monday see effect if any.
The better than expected cohort1 results produced downward trend so Who The F**K Knows.
The Corhort2 dose double results should be killer for NASH!!
Don't think the Market will give GALT credit, I think some larger scale Phase2 results required. Or Good possibility of breakthrough designation after Phase1 if model continues to correlate. Cohort2 should prove reversal with FibroScan unless for some bizarre reason cohort1 tests are out 180.
Simple logic.
Model correlation has been observed.
Higher dose should yield improved results, no TOX so sky is limit. It's just a matter of time.
I picked up some Oct calls a bit back, hope GALT can at least crack $20 on the cohort2 results, be nice to get back some of the beating I took on the April2014 Calls. Still having fun though.
AF and the usual suspects can't keep this down for ever, someday investors will be rewarded for the continued forward positive progress of GALT.
GLTA
Market Data 
Markets 
AI
